Tape Versus Semirigid Versus Lace-up Ankle Support in the Treatment of Acute Lateral Ankle Ligament Injury.
Launched by GELRE HOSPITALS · May 18, 2010
Trial Information
Current as of April 30, 2025
Completed
Keywords
ClinConnect Summary
This study is designed as a single blind prospective randomized controlled trial to evaluate the difference in functional outcome after treatment with tape versus semi-rigid versus lace-up ankle support (brace) for grade II and III acute lateral ankle ligament injuries. The patients will be randomly allocated into one of the three groups. Randomization will be performed by computer. Blinding of patients is not possible, but the observer will be blinded at eight weeks and six months.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients \> 18 years
- • Grade II or III ankle sprains
- • Presentation \< 72 hours after the acute injury
- Exclusion Criteria:
- • Patients with a history of chronic instability
- • Who had a fracture on X-ray investigation
- • Other injuries or disabilities on the same limb
- • Alcoholism, serious psychiatric and neurological illness
- • Patients with bilaterally sprained ankles
- • Patients with previous surgery on the lateral ankle ligaments
- • Skin diseases where taping is not practicable
- • Patients who are unable to give informed consent
- • Patients who are unable to fill out questionnaires
- • Neuromuscular disorders of the lower extremities
- • Active rheumatoid arthritis
- • Gait disturbances
About Gelre Hospitals
Gelre Hospitals is a leading healthcare institution dedicated to advancing medical research and patient care through rigorous clinical trials. With a commitment to innovation and excellence, Gelre Hospitals collaborates with multidisciplinary teams to explore new treatment modalities and improve health outcomes. The organization prioritizes patient safety and ethical standards, ensuring that all trials are conducted in compliance with regulatory guidelines. By fostering a culture of continuous improvement and collaboration, Gelre Hospitals aims to contribute significantly to the field of medicine and enhance the quality of life for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Apeldoorn, , Netherlands
Patients applied
Trial Officials
Eric EJ Raven, MD
Principal Investigator
Gelre Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials